prostaglandin EP4 receptor agonists (Merck & Co)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameprostaglandin EP4 receptor agonists (Merck & Co)
Drug Alias NameEP4 agonist (Merck Frosst)L-000902688L-902688
ClassificationSmall molecules
Mechanisms of ActionBone metabolism modulatorsProstanoid EP4 receptor agonists
TargetsProstanoid EP4 receptor
Therapy Area/IndicationsInflammationGlaucomaOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Canada IncMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsInflammationGlaucomaOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A